# FOCUS Fatigue Outcome in Copaxone USers

> **NCT00267319** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 111 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Glatiramer acetate

## Key facts

- **NCT ID:** NCT00267319
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2006-10
- **Final completion:** —
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2009-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00267319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00267319, "FOCUS Fatigue Outcome in Copaxone USers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00267319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*